
Ralph J. Gitomer
Examiner (ID: 10080, Phone: (571)272-0916 , Office: P/1657 )
| Most Active Art Unit | 1657 |
| Art Unit(s) | 1803, 2899, 1651, 1657, 1815, 1655, 1627, 1623, 1622, 1211 |
| Total Applications | 3335 |
| Issued Applications | 2109 |
| Pending Applications | 286 |
| Abandoned Applications | 943 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6664095
[patent_doc_number] => 20030203421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Stabilized tetrazolium reagent compositions and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 10/431668
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5975
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203421.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431668 | Stabilized tetrazolium reagent compositions and methods for using the same | May 7, 2003 | Abandoned |
Array
(
[id] => 7444265
[patent_doc_number] => 20040009513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/429223
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14643
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429223 | pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof | May 1, 2003 | Issued |
Array
(
[id] => 7674713
[patent_doc_number] => 20040127405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Methods for treating lung infections and lung tumors and for treating and preventing lung metastases'
[patent_app_type] => new
[patent_app_number] => 10/412547
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4266
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127405.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412547 | Methods for treating lung infections and lung tumors and for treating and preventing lung metastases | Apr 10, 2003 | Abandoned |
Array
(
[id] => 7436102
[patent_doc_number] => 20040002458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Pharmaceutical compositions and methods using natriuretic peptides'
[patent_app_type] => new
[patent_app_number] => 10/402021
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11424
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10402021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/402021 | Pharmaceutical compositions and methods using natriuretic peptides | Mar 26, 2003 | Issued |
Array
(
[id] => 5648454
[patent_doc_number] => 20060134186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Oxygenating agents for enhancing host responses to microbial infections'
[patent_app_type] => utility
[patent_app_number] => 10/509285
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12223
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509285 | Oxygenating agents for enhancing host responses to microbial infections | Mar 25, 2003 | Abandoned |
Array
(
[id] => 5912911
[patent_doc_number] => 20060127973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/507908
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6682
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127973.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507908 | Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof | Mar 18, 2003 | Abandoned |
Array
(
[id] => 884963
[patent_doc_number] => 07351800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-01
[patent_title] => 'Stabilized albumin preparations'
[patent_app_type] => utility
[patent_app_number] => 10/505783
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3761
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/351/07351800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505783
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505783 | Stabilized albumin preparations | Feb 27, 2003 | Issued |
Array
(
[id] => 6741816
[patent_doc_number] => 20030159185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Replication protein A and use'
[patent_app_type] => new
[patent_app_number] => 10/372686
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18464
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20030159185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10372686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/372686 | Replication protein A and use | Feb 20, 2003 | Abandoned |
Array
(
[id] => 545863
[patent_doc_number] => 07164002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'FVIIa antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/356257
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 16480
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/164/07164002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356257 | FVIIa antagonists | Jan 29, 2003 | Issued |
Array
(
[id] => 7397081
[patent_doc_number] => 20040038869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Inhibitors of complement activation, their preparation and use'
[patent_app_type] => new
[patent_app_number] => 10/168948
[patent_app_country] => US
[patent_app_date] => 2003-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12405
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168948 | Inhibitors of complement activation, their preparation and use | Jan 8, 2003 | Abandoned |
Array
(
[id] => 6991605
[patent_doc_number] => 20050090642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Fluorescent protein'
[patent_app_type] => utility
[patent_app_number] => 10/498505
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9459
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090642.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498505 | Fluorescent protein | Dec 19, 2002 | Issued |
Array
(
[id] => 715821
[patent_doc_number] => 07053050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Preventives/remedies for proliferative organ diseases chronic arthritic diseases, hypertrophic scar or keloid'
[patent_app_type] => utility
[patent_app_number] => 10/494433
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10459
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494433 | Preventives/remedies for proliferative organ diseases chronic arthritic diseases, hypertrophic scar or keloid | Oct 31, 2002 | Issued |
Array
(
[id] => 724615
[patent_doc_number] => 07045505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Methods of using 69039, a novel human Na/Ca exchanger family member'
[patent_app_type] => utility
[patent_app_number] => 10/256537
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 50248
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10256537
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/256537 | Methods of using 69039, a novel human Na/Ca exchanger family member | Sep 26, 2002 | Issued |
Array
(
[id] => 7605362
[patent_doc_number] => 07115567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Purified STAT proteins and methods of purifying thereof'
[patent_app_type] => utility
[patent_app_number] => 10/245120
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 29018
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245120 | Purified STAT proteins and methods of purifying thereof | Sep 16, 2002 | Issued |
| 10/236177 | Novel human proteins, polynucleotides encoding them and methods of using the same | Sep 5, 2002 | Abandoned |
Array
(
[id] => 7146476
[patent_doc_number] => 20050119459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Late gestation lung genes, fragments and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/488528
[patent_app_country] => US
[patent_app_date] => 2002-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 38194
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488528 | Late gestation lung genes, fragments and uses thereof | Sep 3, 2002 | Abandoned |
Array
(
[id] => 6658373
[patent_doc_number] => 20030133967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Multilayer collagen matrix for tissue reconstruction'
[patent_app_type] => new
[patent_app_number] => 10/231629
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15096
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231629
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231629 | Multilayer collagen matrix for tissue reconstruction | Aug 29, 2002 | Abandoned |
Array
(
[id] => 6800833
[patent_doc_number] => 20030095997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Natural polymer-based material for use in human and veterinary medicine and method of manufacturing'
[patent_app_type] => new
[patent_app_number] => 10/231628
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9916
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20030095997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231628 | Natural polymer-based material for use in human and veterinary medicine and method of manufacturing | Aug 29, 2002 | Abandoned |
Array
(
[id] => 7019441
[patent_doc_number] => 20050221460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton'
[patent_app_type] => utility
[patent_app_number] => 10/487475
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16088
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487475 | Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton | Aug 20, 2002 | Abandoned |
Array
(
[id] => 876774
[patent_doc_number] => 07358337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Assay for low molecular weight heparin'
[patent_app_type] => utility
[patent_app_number] => 10/222345
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5825
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358337.pdf
[firstpage_image] =>[orig_patent_app_number] => 10222345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/222345 | Assay for low molecular weight heparin | Aug 15, 2002 | Issued |